A.G.Un.Co. Obstetrics and Gynaecology Center, Rome, Italy.
Breast Dis. 2024;43(1):243-249. doi: 10.3233/BD-240012.
The management of mastodynia plays a central role in improving women quality of life. Despite its high occurrence, specific therapeutic guidelines for mastalgia are still lacking. Available therapies include unspecific anti-inflammatories, even though they may often expose to undesirable effects and low compliance.
The aim of this study was to highlight the efficacy of the topical application of combined natural molecules including Boswellia serrata, Betaine and myo-Inositol in improving cyclic mastalgia.
In this retrospective pilot clinical study, patients with cyclic mastalgia applied a specific breast gel for three months. The severity of the pain was measured through the Visual Analogue Score (VAS) in the treated group compared to untreated one. Treated patients also filled in a questionnaire evaluating acceptance and safety of the breast gel.
This pilot clinical study demonstrated for the first time the efficacy of the topical application of a breast gel based on Betaine, Boswellia serrata, and myo-Inositol in improving cyclic mastodynia. The completed questionnaires also revealed high levels of acceptance, as both safety and compliance.
Besides confirming the positive effects of these natural molecules in the management of conditions affecting breast physiology - so far evaluated as oral supplementation - the obtained results pave the way for further studies supporting the use of such molecules as a tailored medical device in the management of breast pain, thus also opening toward a combined oral and topical approach.
乳房痛的管理对于提高女性生活质量起着核心作用。尽管其发病率很高,但针对乳房痛的具体治疗指南仍缺乏。现有的治疗方法包括使用非特异性抗炎药,尽管它们可能经常会引起不良作用和低顺应性。
本研究旨在强调包括乳香、甜菜碱和肌醇在内的天然复合分子的局部应用在改善周期性乳房痛方面的疗效。
在这项回顾性的初步临床研究中,患有周期性乳房痛的患者使用特定的乳房凝胶治疗三个月。与未治疗组相比,通过视觉模拟评分(VAS)来衡量治疗组疼痛的严重程度。接受治疗的患者还填写了一份问卷,评估乳房凝胶的接受度和安全性。
这项初步临床研究首次证明了基于甜菜碱、乳香和肌醇的乳房凝胶局部应用在改善周期性乳房痛方面的疗效。完成的问卷还显示出较高的接受度,因为安全性和顺应性都很高。
除了证实这些天然分子在管理影响乳房生理的疾病方面的积极作用(迄今为止已评估为口服补充剂)之外,所获得的结果为进一步的研究提供了支持,这些研究支持将此类分子作为一种针对乳房疼痛的定制医疗设备进行使用,从而也为口服和局部联合治疗方法开辟了道路。